Filing Details
- Accession Number:
- 0001209191-21-032165
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-12 13:00:00
- Reporting Period:
- 2021-05-10
- Accepted Time:
- 2021-05-12 17:47:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 16040 | Cabot Corp | CBT | Miscellaneous Chemical Products (2890) | 042271897 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1778734 | A Karen Kalita | C/O Cabot Corporation Two Seaport Lane, Suite 1400 Boston MA 02210 | Svp And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-10 | 6,862 | $40.91 | 21,687 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-05-10 | 5,533 | $62.72 | 16,154 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-05-10 | 5,898 | $50.23 | 22,052 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-05-10 | 5,224 | $62.97 | 16,828 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Acquisiton | 2021-05-10 | 6,862 | $0.00 | 6,862 | $40.91 |
| Common Stock | Stock Options | Acquisiton | 2021-05-10 | 5,898 | $0.00 | 5,898 | $50.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,575 | 2029-06-02 | No | 4 | M | Direct | |
| 13,764 | 2029-11-07 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 540 | Indirect | Through the Trustee for the Corporation's 401(k) Plan |
Footnotes
- Consists of shares sold to cover stock option exercise price and taxes due upon exercise of such stock options; balance of shares issued upon exercise of stock options were held. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $62.67 to $62.74, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.
- Consists of shares sold to cover stock option exercise price and taxes due upon exercise of such stock options; balance of shares issued upon exercise of stock options were held. The price reported is a weighted average sale price. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $62.92 to $62.99, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.
- 11,437 shares were subject to the option. The option vests over a three year period as follows: 30% on November 9, 2019, 30% on November 9, 2020 and 40% on November 9, 2021.
- 19,662 shares were subject to the option. The option vests over a three year period as follows: 30% on November 8, 2020, 30% on November 8, 2021 and 40% on November 8, 2022.
Billionaire Hedge Funds
